Related Experiment Video
Updated: Aug 7, 2026
10:10
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Ultrasmall Cyclodextrin-Based Nanogels as Drug Delivery Systems
Andrea Cesari1, Simona Braccini1, Maria Antonietta Casulli2
1Department of Chemistry and industrial Chemistry, University of Pisa, Pisa, Italy.
Chemistryopen
|August 4, 2026
Summary
Cyclodextrin-based nanogels effectively deliver hydrophobic anticancer drugs. These biocompatible nanogels enhance drug efficacy against cancer cells, showing promise for future cancer therapies.
Area of Science:
- Nanotechnology
- Materials Science
- Pharmacology
Background:
- Poorly water-soluble anticancer agents face delivery challenges.
- Cyclodextrin-based nanogels (CDngs) offer a potential solution for drug encapsulation.
Purpose of the Study:
- To evaluate ultrasmall cyclodextrin-based nanogels (CDngs) as a novel drug delivery system for hydrophobic anticancer agents.
- To assess the encapsulation efficiency, biocompatibility, and anticancer efficacy of CDngs loaded with Combretastatin A-4 (CA-4).
Main Methods:
- Development of ultrasmall CDngs crosslinked with ethylene glycol diglycidyl ether (EGDE).
- Encapsulation of hydrophobic anticancer agents, specifically Combretastatin A-4 (CA-4), within the nanogel platform.
- In vitro assessment of nanogel biocompatibility and the cytotoxic effects of drug-loaded nanogels on A2780 cancer cell lines.
Main Results:
- The γ-cyclodextrin (γ-CD) based nanogels demonstrated high encapsulation efficiency for CA-4, despite suboptimal host-guest fit.
- Empty γ-CDngs showed no cytotoxicity, confirming their intrinsic biocompatibility.
- CA-4 loaded γ-CDngs retained and enhanced the cytotoxic properties of the free drug against the A2780 cancer cell line.
Conclusions:
- Ultrasmall cyclodextrin-based nanogels (CDngs) represent a promising platform for delivering hydrophobic anticancer drugs.
- CDngs enhance the therapeutic efficacy of anticancer agents while maintaining biocompatibility.
- This innovative nanogel system holds potential for further development in cancer therapy.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...